
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 4.64% on an annualized basis producing an average annual return of 15.92%. Currently, Halozyme Therapeutics has a market capitalization of $8.38 billion. Buying $100 In HALO: If ... Full story available on…
Full Article